logo

For the Inventor, By the Inventor

Heidelberg, Germany

Deutsches Krebsforschungszentrum


USPTO Granted Patents = 155



Forward Citations = 641

Loading Chart...
Loading Chart...

356 inventors (with patents filed for the assignee):

goldMedal Jean Rommelaere (23 out of 33 patents)

silverMedal Barbara Leuchs (12 out of 14 patents)

bronzeMedal Johann Engelhardt (11 out of 102 patents)

4.  Matthias Eder (11 out of 13 patents)

5.  Klaus Kopka (11 out of 13 patents)

6.  Uwe Haberkorn (10 out of 20 patents)

7.  Michael Platten (9 out of 12 patents)

8.  Antonio Marchini (9 out of 9 patents)

9.  Karsten Geletneky (8 out of 12 patents)

10.  Benjamin Bader (8 out of 30 patents)

11.  Martina Benesova (7 out of 9 patents)

12.  Martin Schaefer (7 out of 7 patents)

13.  Ulrike Bauder-Wuest (7 out of 7 patents)

14.  Gerhard Moldenhauer (7 out of 11 patents)

15.  Norbert Schmees (6 out of 28 patents)


Core Competencies:
Radiologic Treatment
Molecular Imaging
Oncolytic Virus Therapy
Cancer Vaccines
Genetic Modification
Prostate Cancer Imaging
Immune Activation
Diagnostic Assays
Fibrosis Treatment
Antibody Combinations
Ultrasonic Probes
RNA Viruses

155 patents:

1. 12397177 - Test system for testing a system for radiologic treatment (2025-08-26),
2. 12285633 - Device and a method for monitoring a treatment of a body part of a patient with particles (2025-04-29),
3. 12221479 - Pharmaceutical combination of anti CEACAM6 and TIM3 antibodies (2025-02-11),
4. 12215335 - Non-integrating DNA vectors for the genetic modification of cells (2025-02-04),
5. 12161708 - Combined prophylactic and therapeutic vaccines (2024-12-10),
6. 12156920 - Double-labeled probe for molecular imaging and use thereof (2024-12-03),
7. 12054458 - F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer (2024-08-06),
8. 11998539 - Substituted aminoquinolones as DGKalpha inhibitors for immune activation (2024-06-04),
9. 11964953 - Substituted aminothiazoles as DGKzeta inhibitors for immune activation (2024-04-23),
10. 11964015 - Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor (2024-04-23),
11. 11899089 - Phantom calibration body and method for determining at least one quantitative diffusion parameter extracted for characterization of a tissue in magnetic resonance imaging (2024-02-13),
12. 11862320 - Control device for controlling at least one collimator (2024-01-02),
13. 11836831 - Method for generating an image of an object from measurement data (2023-12-05),
14. 11806395 - Epstein-Barr virus-like particles with broadened antigenic spectrum (2023-11-07),
15. 11795164 - 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer (2023-10-24),
The Deutsches Krebsforschungszentrum (DKFZ) is a German Cancer Research Center located in Heidelberg, Germany. It is one of the leading institutes dedicated to cancer research globally. DKFZ conducts extensive scientific research, investigating the causes and progression of cancer, and developing innovative and effective strategies for prevention, diagnosis, and treatment. Their multidisciplinary approach involves collaborations with universities, hospitals, and research institutions worldwide. Through their work, DKFZ aims to contribute to the understanding of cancer and ultimately improve patients' lives by providing more effective diagnostic and therapeutic approaches.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
155 Patents

#3 in Heidelberg

#423 in Germany

#5,157 in the World

...
Heidelberg, Germany

Deutsches Krebsforschungszentrum

Forward Citations = 641

356 inventors:

goldMedal Jean Rommelaere (23 out of 33 patents)

silverMedal Barbara Leuchs (12 out of 14 patents)

bronzeMedal Johann Engelhardt (11 out of 102 patents)

4.  Matthias Eder (11 out of 13 patents)

5.  Klaus Kopka (11 out of 13 patents)

Please report any incorrect information to support@idiyas.com
Loading…